Atlas Trials

Trial of Afatinib With Paclitaxel for Neoadjuvant Therapy of TNBC and Research of Biomarkers of Afatinib

Clinical trial NCT02511847 · UNKNOWN

Trial details

NCT number
NCT02511847
Sponsor
National Taiwan University Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Triple Negative Breast Cancer
Start date
2015-08-01
Primary completion
2017-07-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.